The Tensilon test is a method to help diagnose myasthenia gravis.
Myasthenia gravis - Tensilon test; Edrophonium test
A medicine called Tensilon (also called edrophonium) is given during this test. The health care provider gives the medicine through one of your veins (intravenously, through an IV). You may also be given a medicine called atropine before receiving Tensilon to reduce chances of side effects. Your heart rate may be monitored to make sure the medicine doesn't slow your heart down.
You will be observed for any improvement in strength from the medicine. Muscles that are weak will be tested before and right after the medicine is given. Any weak muscles are monitored, although the muscles of the eyes or face are most commonly tested.
The test may be repeated and you may have other Tensilon tests to help tell the difference between myasthenia gravis and other conditions.
No special preparation is usually necessary. Follow your provider's instructions about how to prepare.
You will feel a sharp prick as the IV needle is inserted. The medicine may cause a feeling of a churning of the stomach or a slight feeling of decreased heart rate, especially if atropine is not given first.
The test helps:
The test may also be done for conditions such as Lambert-Eaton syndrome. This is a disorder in which faulty communication between nerves and muscles leads to muscle weakness.
In many people with myasthenia gravis, the muscle weakness will improve right after receiving Tensilon. The improvement lasts only a few minutes. For some types of myasthenia, Tensilon may make the weakness worse.
When the disease gets worse enough to need treatment (myasthenic crisis), there is a brief improvement in muscle strength.
When there is an overdose of anticholinesterase (cholinergic crisis), Tensilon will make the person even weaker.
The medicine used during the test may cause side effects, including low heart rate, fainting, nausea, or breathing failure. This is why the test is done by a provider in a medical setting.
Guptill JT, Sanders DB. Disorders of neuromuscular transmission. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 108.
Naji A, Owens ML. Edrophonium. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. www.ncbi.nlm.nih.gov/books/NBK554566/. Published January 2022. Updated September 3, 2022.
Zhou J, Nozari A, Bateman B, Allen PD, Pessah IN. Neuromuscular disorders including malignant hyperthermia and other genetic disorders. In: Gropper MA, ed. Miller's Anesthesia. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 35.
Review Date:
1/23/2023 Reviewed By: Joseph V. Campellone, MD, Department of Neurology, Cooper Medical School of Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. |